IL-23, and IL-17 were associated with a lower rate of serious infections among older adults with psoriatic disease, a ...

Senators question Pfizer's partnership with UpScriptHealth, citing potential anti-kickback concerns and risks of increased ...

John Kenney Jr., MD, Lifetime Achievement Award and Lectureship recipient Pearl E. Grimes, MD, FAAD, delivered a tribute to her predecessor as she discussed the history and advancements of vitiligo.

Pfizer's strong fundamentals, impressive R&D achievements, and undervalued metrics underscore its defensive appeal and growth ...

Higher-priced drugs, including Vyndaqel, Ibrance, Xtandi and Xeljanz, are expected to be most affected by the IRA. Pfizer expects Comirnaty and Paxlovid to maintain market share in 2025 with ...

Pfizer reported fourth-quarter 2024 adjusted ... However, sales of some key drugs like Prevnar, Xeljanz and Ibrance and new RSV vaccine, Abrysvo declined in the quarter. Seagen drugs contributed ...

Xeljanz, Xtandi, and Inlyta. All these products generated around $26 billion in sales during FY2024, which is a vast portion of the total $63 billion revenue. Pfizer works really hard on ...

Pfizer Research & Development Introduced a new class of oral medications for autoimmune diseases dominated by biologics, including first-in-class JAK inhibitor Xeljanz (tofacitinib) for rheumatoid ...

JAK inhibitor Xeljanz is one of Pfizer’s top-selling drugs, despite a ‘black box’ warning for blood clots and cancers added to its label in 2019. Now, a study designed to prove its safety ...

Conservative commentator Megyn Kelly claimed the Pfizer COVID vaccine left her with an auto-immune disorder in explosive new comments on her latest podcast episode Wednesday. Kelly, 54 ...

IsomAb makes two key appointments; Dr Shi Yin Foo M.D. as Non-Executive Director and Dr Gary Burgess M.D. as Chief Medical Officer ...